Interesting in breast cancer we previously showed that high RECQL5 protein level needed to be associated with low RAD51 protein expression to infer poor survival, suggesting a functional relationship between RECQL5 and RAD51 pathways influences breast cancer tumour progression or response to therapy [25]. This evidence concerns the gene RAD51 and breast carcinoma.